Akademik Veri Yönetim Sistemi
Cardiovascular surgery and interventions, cilt.11, sa.1, ss.26-32, 2024 (Hakemli Dergi)
Objectives: This study aimed to share our experiences using extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease 2019 (COVID-19) to explain the mechanisms of disease and death related to COVID-19 and improve ECMO supportive treatment. Patients and methods: This retrospective study was conducted with 26 COVID-19 patients (10 males, 16 females; mean age: 34.4±11.5 years; range, 12 to 59 years) who received ECMO support between January 1, 2021, and December 31, 2021. A multidisciplinary team closely followed patients with COVID-19 who required ECMO support. The data were carefully recorded, and their effects on ECMO follow-up and the results obtained were examined. Results: Only 34.6% of the patients were able to come off ECMO support, and the mortality rate during ECMO support was 80.8%. However, the mortality rate for weaned patients decreased significantly over the last six months. Conclusion: Overall, our findings suggest that ECMO intervention should be done early for better treatment outcomes, and mild sedation in ECMO follow-up for COVID-19 patients is linked to lower mortality rates.